Back
ESC Premium Access

Obesity, and low high-density lipoprotein are residual cardiovascular risks despite optimal low-density lipoprotein reduction with statins: a substudy of the ESCORT trial

Session: Poster session 2 - Coronary artery disease: from bench to bedside
Topic: Inflammation and microcirculation
Speaker: Doctor Y. Katayama (Wakayama, JP)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Doctor Yosuke Katayama

Wakayama Medical University, Wakayama (Japan)
0 follower

71 more presentations in this session

Extended duration betrixaban in acutely ill medical patients is associated with reduction in fatal or irreversible ischemic or bleeding events compared with standard dose enoxaparin: an APEX substudy

Speaker: Doctor G. Chi (Boston, US)

Access
Abstract
Slides
Like
Thumbnail

Proprotein convertase subtilisin/kexin type 9 (PCSK9), platelet activation and risk of cardiovascular events in atrial fibrillation

Speaker: Professor P. Pignatelli Spinazzola (Rome, IT)

Access
Abstract
Slides
Like
Thumbnail

Factor V Leiden related risk of thromboembolic and bleeding complications in patients with established coronary heart disease.

Speaker: Doctor B. Mahmoodi (Rotterdam, NL)

Access
Abstract
Slides
Like
Thumbnail

Factor V Leiden and prothrombin G20210A mutations in patients with premature myocardial infarction.

Speaker: Professor L. Rallidis (Athens, GR)

Access
Abstract
Slides
Like
Thumbnail

Angiographic and hemodynamic modifications of Myocardial Bridge during supine bicycle exercise

Speaker: Doctor J. Adjedj (Saint Laurent du Var, FR)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 2 - Coronary artery disease: from bench to bedside

Speakers: Doctor Y. Katayama, Doctor G. Chi, Professor P. Pignatelli Spinazzola, Doctor B. Mahmoodi, Professor L. Rallidis...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources